Early research (Phase 1)Study completedNCT05938075
What this trial is testing
Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa
Who this might be right for
SARS-CoVSARS-CoV-2
Vaccine Company, Inc. 130
Showing 20 of 0 results